FDA’s Bombshell: Could Vaccines Be Fatal?

Time,To,Vaccinate,Concept.,Closeup,Cropped,View,Of,Unrecognizable,Young

The FDA’s investigation into pediatric deaths potentially linked to COVID-19 vaccines is revealing unsettling truths that could change vaccine policies forever.

Story Overview

FDA investigates potential link between COVID-19 vaccines and pediatric deaths.
Investigation driven by reports from VAERS, a system for unverified vaccine adverse event reporting.
Power shift in federal health agencies with Robert F. Kennedy Jr.’s leadership.
Potential implications for vaccine policy and public trust in health agencies.

FDA’s Intense Investigation

The FDA, under the leadership of Commissioner Marty Makary, is conducting an intensive investigation into reports of pediatric deaths potentially linked to COVID-19 vaccines. This investigation, announced in September 2025, stems from submissions to the Vaccine Adverse Event Reporting System (VAERS), which collects unverified reports of adverse events. The agency plans to present data linking more than two dozen pediatric deaths to the vaccines at a meeting of the CDC’s Advisory Committee on Immunization Practices (ACIP).

The investigation coincides with recent leadership changes, including the appointment of Robert F. Kennedy Jr. as Health and Human Services Secretary. Kennedy, a known vaccine skeptic, has long criticized federal vaccine monitoring systems as inadequate, pushing for more rigorous scrutiny and transparency in vaccine safety data.

Leadership Transition and Policy Changes

In April 2025, Kennedy’s appointment marked a significant ideological shift within federal health agencies, emphasizing increased scrutiny of vaccine safety. His leadership has already sparked debates over the adequacy of current vaccine safety monitoring systems like VAERS. Despite VAERS being a valuable tool for tracking potential vaccine-related adverse events, its unverified nature means that reports require thorough investigation to establish causation.

Former CDC Director Rochelle Walensky expressed concerns about the integrity of vaccine safety information under Kennedy’s leadership. She warned that vaccine data on the CDC’s website might not be entirely accurate, reflecting institutional tensions over the direction of vaccine policy and communication.

Public and Expert Reactions

The FDA’s investigation has drawn mixed reactions from the medical community and the public. While some see it as necessary scrutiny, others view it as an investigation into unsubstantiated claims. The medical community maintains that COVID-19 vaccines are safe and that no credible evidence supports the claims of vaccine-caused pediatric deaths. The only significant safety signal identified has been rare cases of myocarditis in young men receiving mRNA vaccines.

Experts emphasize that VAERS reports are temporal associations, not proof of causation. The database, open to reports from anyone, contains unverified claims that require rigorous epidemiological analysis to establish causation. The FDA’s investigation will rely heavily on reviewing autopsy reports and interviewing families to determine whether the reported deaths have any causal link to the vaccines.

Implications and Future Outlook

The outcome of the FDA’s investigation could have significant implications for vaccine recommendations and public trust. If the investigation concludes a causal link between the vaccines and pediatric deaths, it could lead to a major policy shift and potentially reduce pediatric vaccination rates. Conversely, if no causal link is found, it might reinforce existing vaccine safety data but could be perceived as a cover-up by vaccine skeptics, further polarizing public opinion.

FDA officials: At least 10 children died due to COVID shots https://t.co/qimi9XXTVF via @OANN

— Shelley Peterson (@ShelleyP711) November 29, 2025

The investigation’s findings are eagerly anticipated, as they will likely influence future vaccine policy decisions and public health strategies. The ACIP meeting, where the FDA will present its findings, represents a critical juncture for determining the direction of COVID-19 vaccine recommendations for children.